KOBO Biotech Ltd
Ticker: KOBO
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
3.10
Market Cap
6.72
Debt/Equity
ROE %
PB
-0.0525
Promoter %
44.949
Pledge %
0.000
1Y Rev Growth %
0.000
5Y Rev Growth %
-7.789
NP Margin %
-9999.999
NP Margin 5Y Avg %
-9999.999
Trading Reference
1M Return %
30.396
6M Return %
3.333
1Y Return %
5.085
% Away 52W High
47.097
% Away 52W Low
49.038
Daily Volume
10854
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 32/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
KOBO Biotech Ltd shows potential in the biotech sector with innovative products but faces market challenges.
✅ Positives
- Strong pipeline of innovative biotech products
- Growing demand for biotech solutions in India
- Experienced management team with industry expertise
⚠️ Negatives
- High competition in the biotech market
- Regulatory hurdles may delay product launches
- Limited financial history and profitability concerns
Verdict
Cautiously optimistic about future growth.
Recommendation: Consider buying on dips for long-term gains.
Upside Probability: 30% | Downside Probability: 20%
Last generated: 30/10/2025
More Options
O
Ortel Communications Ltd
Ortel Communications Ltd presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
P
Prashant India Ltd
Prashant India Ltd shows potential in a future-ready sector, but inconsistent growth and profitability metrics raise concerns. Valuation appears stretched, and governance issues could pose risks.
View details
A
ADITYA BSL Nifty 200 Quality 30 ETF
The ETF has a decent score reflecting a balanced approach towards quality investments, though some risks remain.
View details
C
Continental Controls Ltd
Continental Controls Ltd presents a risky investment profile with inconsistent growth and profitability metrics, coupled with weak market sentiment.
View details
V
Virgo Global Ltd
Virgo Global Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vallabh Steels Ltd
Vallabh Steels Ltd shows potential but faces significant risks and challenges in growth and profitability, making it a risky investment at this time.
View details
J
Jointeca Education Solutions Ltd
Jointeca Education Solutions Ltd presents a risky investment profile with several concerns regarding profitability and valuation metrics.
View details
U
Unitech International Ltd
Unitech International Ltd presents several risks with inconsistent financial performance and weak market sentiment, making it a risky investment at this time.
View details
M
Multipurpose Trading and Agencies Ltd
The stock presents several risks, including inconsistent growth and weak governance, making it a risky investment.
View details
A
Aadi Industries Ltd
Aadi Industries Ltd shows potential but faces significant challenges in profitability and valuation. Caution is advised for investors.
View details
M
MPAgro Industries Ltd
MPAgro Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Q
Quintegra Solutions Ltd
Quintegra Solutions Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
O
Olympic Cards Ltd
Olympic Cards Ltd shows potential in a niche market but faces significant risks and inconsistencies in growth and profitability metrics. Caution is advised for potential investors.
View details
I
Integrated Thermoplastics Ltd
Integrated Thermoplastics Ltd shows potential in a growing sector, but faces significant challenges in profitability, valuation, and market sentiment.
View details
5
52 Weeks Entertainment Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Mahalaxmi Seamless Ltd
Mahalaxmi Seamless Ltd shows potential in a growing sector, but inconsistent growth and valuation concerns warrant caution.
View details
Business Overview
KOBO Biotech Ltd is a leading biotechnology company focused on innovative solutions for healthcare and agriculture. Catering to both the medical and agricultural sectors, KOBO is committed to enhancing quality of life through advanced biotechnological research and development. Their cutting-edge products are designed to meet the needs of a growing population, ensuring sustainability and health improvements.
- Innovative biotechnology solutions for healthcare and agriculture.
- Focus on sustainability and quality of life enhancement.
- Strong commitment to research and development.
- Tailored products for diverse market needs.
- Dedicated to improving health outcomes and agricultural efficiency.
Investment Thesis
KOBO Biotech Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to industry peers. These factors position the company for sustained growth and profitability, making it a noteworthy addition to any investor's portfolio.
- Strong promoter group with a proven track record in the biotech sector.
- Rapidly expanding digital services segment, tapping into growing market demand.
- Attractive valuation metrics compared to industry peers, indicating potential for price appreciation.
- Robust pipeline of innovative products set to drive future revenue growth.
- Commitment to R&D ensures KOBO remains competitive in the evolving biotech landscape.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Strong pipeline of innovative products
- Strategic partnerships with major firms
- Expanding market presence in Asia
Risks ⚠️
- Regulatory hurdles in drug approvals
- High competition in biotech sector
- Dependence on successful product launches
- Market volatility affecting stock prices
Peer Perspective
KOBO Biotech Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating in the stock.
Future Outlook
KOBO Biotech Ltd is well-positioned for growth, driven by its innovative pipeline and strategic partnerships. Successful execution of its development plans and effective cost management will be crucial to unlocking its full potential.
AI FAQs for Retail Users
- Q: What does KOBO Biotech Ltd do?A: KOBO Biotech Ltd focuses on biotechnology research and development, particularly in innovative healthcare solutions.
- Q: Is KOBO Biotech Ltd listed on Indian stock exchanges?A: Yes, KOBO Biotech Ltd is listed on major Indian stock exchanges for trading.
- Q: What are the risks of investing in KOBO Biotech Ltd?A: Investing in biotechnology stocks can be volatile due to regulatory approvals and market competition.
- Q: How can I buy shares of KOBO Biotech Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What should I consider before investing in KOBO Biotech Ltd?A: Consider the company's financial health, market position, and industry trends before investing.
📊 Stock Investment Checklist (100 Points)
KOBO Biotech Ltd • Updated: 2025-09-17 14:28:06
-
10BusinessHighThe biotech sector shows potential but lacks a strong moat.
-
10GrowthHighRevenue growth is inconsistent with fluctuating profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, indicating profitability concerns.
-
9ValuationHighP/E and P/B ratios are higher than peers, suggesting overvaluation.
-
6BalanceGoodModerate debt levels but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some pledging issues.
-
5DriversGoodLimited growth drivers and significant execution risks.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
KOBO Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100